NTRA241220C70000
- 0.00
- 0.000.00%
Natera Newsroom
Express News | Form 144 | Natera(NTRA.US) Director Proposes to Sell 14.79 Million in Common Stocks
Why Is Natera, Inc. (NTRA) Among the Best High Growth Healthcare Stocks to Invest In Now?
Looking Into Natera's Recent Short Interest
Clinical Validation Study on Natera's Fetal RhD NIPT Published in Obstetrics & Gynecology
Natera, Inc.'s (NASDAQ:NTRA) 32% Price Boost Is Out Of Tune With Revenues
Insider Sale: EXECUTIVE CHAIRMAN of $NTRA (NTRA) Sells 400 Shares
Express News | Natera Announces Medicare Coverage for Prospera™ in Single Lung Transplant Recipients
Piper Sandler Maintains Natera(NTRA.US) With Buy Rating, Maintains Target Price $200
Piper Sandler Sticks to Their Buy Rating for Natera (NTRA)
Trade Alert: Independent Director Of Natera Gail Marcus Has Sold Stock
Express News | Guardant Health Says Jury Unanimously Rejected All Of Natera's Counterclaims And Awarded $292.5M To Company, Including $175.5M In Punitive Damages
Express News | Guardant Health Shares Are Trading Higher After a Jury Issued a Decision in the Company's Favor Regarding a False Advertising Case Filed by Natera Concerning Statements Made About Guardant's Reveal Test
Natera Issues Statement On Guardant Health Litigation; Says "A Jury Issued A Decision In Guardant's Favor. We Disagree With This Decision And Will Ask The Court To Overturn It"
Express News | Natera Inc - to Ask Court to Overturn Jury Decision in Guardant Case
JPMorgan Updates Its U.S. Analyst Focus List – Adds TPR, ALRM, REG
Natera to Present New SignateraTM Data in Multiple Abstracts at the San Antonio Breast Cancer Symposium
Natera Issues Statement on Guardant Health Litigation
Natera Co-Founder and Executive Chairman Matthew Rabinowitz Named 2024 R&D Leader of the Year
United States Non-Invasive Prenatal Testing Market Report 2025-2033: Illumina, Roche, and Natera, Which Have Established Themselves as Leaders Through Robust Research and Development
Insider Sale: Director at $NTRA (NTRA) Sells 2,100 Shares